ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,018.39
-0.34%
Dow Jones
37,903.29
0.23%
US Dollar vs MXN
16.9481
0.03%
Brent Oil
83.885
0.41%
Bitcoin
57,381.82
-1.47%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE
  6. Takeda Pharmaceutical Co Ltd (0RN3)

  7. Takeda Pharmaceutical Co Ltd (0RN3) Noticias

0RN3

Takeda Pharmaceutical (0RN3)

Takeda Pharmaceutical Co Ltd
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:LSE:0RN3
FechaHoraFuenteTítuloSímboloCompañía
22/04/202414:41Alliance NewsAlliance NewsTakeda, Astellas and Sumitomo to create new drug discovery companyLSE:0RN3Takeda Pharmaceutical Co Ltd
27/03/202407:56PR Newswire (US)Empathy in Action: Takeda's Global Initiative Brings IBD Challenges to the Forefront in the UAELSE:0RN3Takeda Pharmaceutical Co Ltd
09/11/202306:16Alliance NewsAlliance NewsHutchmed hails Takeda's fruquintinib approval from US for cancer formLSE:0RN3Takeda Pharmaceutical Co Ltd
30/10/202307:24Alliance NewsAlliance NewsTakeda Pharmaceutical first half profit falls as costs outpace revenueLSE:0RN3Takeda Pharmaceutical Co Ltd
29/09/202304:12Alliance NewsAlliance NewsHutchmed notes Takeda submits fruquintinib drug application in JapanLSE:0RN3Takeda Pharmaceutical Co Ltd
22/09/202309:15PR Newswire (US)Takeda Receives Positive CHMP Opinion Recommending Approval of Lanadelumab for Routine Prevention of Recurrent Attacks of Hereditary Angioedema (HAE) in Patients Aged 2 years and OlderLSE:0RN3Takeda Pharmaceutical Co Ltd
27/07/202304:26Alliance NewsAlliance NewsTakeda keeps guidance unchanged despite drop in quarterly profitLSE:0RN3Takeda Pharmaceutical Co Ltd
12/07/202307:22Alliance NewsAlliance NewsJapan's Takeda pulls dengue vaccine candidate in USLSE:0RN3Takeda Pharmaceutical Co Ltd
16/06/202302:51Alliance NewsAlliance NewsHutchmed, Takeda Fresco-2 study published in The LancetLSE:0RN3Takeda Pharmaceutical Co Ltd
11/05/202305:51Alliance NewsAlliance NewsTOP NEWS: Takeda outlook downbeat as Covid wanes, hit from genericsLSE:0RN3Takeda Pharmaceutical Co Ltd
02/02/202304:57Alliance NewsAlliance NewsTakeda Pharmaceutical set for annual guidance as 9-month results upLSE:0RN3Takeda Pharmaceutical Co Ltd
08/12/202210:49Alliance NewsAlliance NewsTakeda Pharmaceutical gets EC approval for dengue vaccineLSE:0RN3Takeda Pharmaceutical Co Ltd
23/11/202206:49Alliance NewsAlliance NewsIN BRIEF: USD FDA accepts Takeda's TAK-003 for priority reviewLSE:0RN3Takeda Pharmaceutical Co Ltd
28/07/202211:10Alliance NewsAlliance NewsTakeda first quarter profit drops despite revenue increaseLSE:0RN3Takeda Pharmaceutical Co Ltd
11/05/202207:23Alliance NewsAlliance NewsTakeda annual profit drops on investment losses but revenue climbsLSE:0RN3Takeda Pharmaceutical Co Ltd
19/04/202202:19Alliance NewsAlliance NewsTakeda's Nuvaxovid vaccine approved for use in JapanLSE:0RN3Takeda Pharmaceutical Co Ltd
07/09/202100:10Alliance NewsAlliance NewsTakeda inks deal with Japan's government to supply Novavax vaccinesLSE:0RN3Takeda Pharmaceutical Co Ltd
09/06/202111:22PR Newswire (US)Takeda introduces the In Their Shoes experience to the Middle East in support of the IBD patient communityLSE:0RN3Takeda Pharmaceutical Co Ltd
11/05/202102:30Alliance NewsAlliance NewsTOP NEWS: Takeda Pharmaceutical profit surges; guides boosted revenueLSE:0RN3Takeda Pharmaceutical Co Ltd
29/10/202002:41Alliance NewsAlliance NewsTOP NEWS: Takeda Pharmaceutical Ups Guidance As Profit Rises In HalfLSE:0RN3Takeda Pharmaceutical Co Ltd
07/08/202005:25Alliance NewsAlliance NewsNovavax Turns To Takeda To Manufacture Covid-19 Vaccine In JapanLSE:0RN3Takeda Pharmaceutical Co Ltd
03/08/202005:35Alliance NewsAlliance NewsGLOBAL TRADING UPDATE SUMMARY: Murata's First-Quarter Profit Drops 15%LSE:0RN3Takeda Pharmaceutical Co Ltd
31/07/202005:04Alliance NewsAlliance NewsTOP NEWS: Takeda Profit More Than Triples In Quarter; Ups GuidanceLSE:0RN3Takeda Pharmaceutical Co Ltd
29/06/202004:06Alliance NewsAlliance NewsTakeda Earnings To Be Hurt By Novartis Pulling Xiidra ApplicationLSE:0RN3Takeda Pharmaceutical Co Ltd
22/06/202004:10Alliance NewsAlliance NewsTakeda Pharmaceutical To Get USD564 Million One-Off Profit BoostLSE:0RN3Takeda Pharmaceutical Co Ltd
15/06/202005:33Alliance NewsAlliance NewsTakeda Pharmaceutical Reports Positive Hemophilia Studies ResultsLSE:0RN3Takeda Pharmaceutical Co Ltd
13/05/202003:15Alliance NewsAlliance NewsTakeda Revenue Rises But Swings To Loss In First Year After Shire BuyLSE:0RN3Takeda Pharmaceutical Co Ltd
02/03/202006:18Alliance NewsAlliance NewsTakeda Pharma Sells Non-Core Latin America Product Portfolio To HyperaLSE:0RN3Takeda Pharmaceutical Co Ltd
04/02/202003:31Alliance NewsAlliance NewsTakeda Boosts Full-Year Revenue Outlook After Nne-Month GrowthLSE:0RN3Takeda Pharmaceutical Co Ltd
08/01/202001:00UK RegulatoryTakeda Pharmaceutical Company Ltd Confirmation of post-offer intention statementsLSE:0RN3Takeda Pharmaceutical Co Ltd
 Showing the most relevant articles for your search:LSE:0RN3

Su Consulta Reciente

NYSE
CVX
Chevron
USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
NVDA
NVIDIA
USOTC
RHHBY
Roche (QX)
NYSE
NKE
Nike
COIN
BTCUSD
Bitcoin
NYSE
BAC
Bank of America
USI
USTECH100
US Tech 100
NASDAQ
MSFT
Microsoft
NYSE
MRK
Merck
SPI
SP500
S&P 500
AMEX
XLV
Health Care Select Sector
NYSE
AXP
American Express
FX
USDMXN
US Dollar vs MXN
NYSE
XOM
Exxon Mobil
PM
XAUUSD
Gold vs US Dollar
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados